Please assess the completion status of the following clinical trial:

Trial Title: The Use of DPP-4 Inhibitors in Short Bowel Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients receiving home parenteral nutrition (HPN) because of short bowel syndrome for at least 12 months~* stable metabolic status~* benign disease~Exclusion Criteria:~* HPN \< 12 months~* metabolically unstable~* cancer as the reason for intestinal failure

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- DPP-4 (Type: EXPERIMENTAL): The administration of the DPP-4 inhibitor in the form of a pill once per day
- NO DPP (Type: NO_INTERVENTION): no therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).